Multiple Sclerosis (MS) stands as one of the most prevalent and debilitating neurological conditions worldwide, affecting over 2.3 million individuals globally. Characterized by chronic inflammation and progressive neurodegeneration, MS presents in diverse forms and severity, significantly impacting patients’ quality of life. Despite advances in therapeutics, current treatments often focus on symptom management and disease control…
